CareRx Announces Q2 2026 Dividend
CareRx (CHHHF) declared a quarterly cash dividend of CAD $0.02 per common share, payable July 9, 2026, to shareholders of record at the close of business on June 23, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareRx (CHHHF) declared a quarterly cash dividend of CAD $0.02 per common share, payable July 9, 2026, to shareholders of record at the close of business on June 23, 2026. The dividend is designated an eligible dividend for Canadian tax purposes; non‑residents may face withholding tax.
Positive
- Declared cash dividend of CAD $0.02 per common share
- Dividend payable on July 9, 2026
- Dividend designated as an eligible dividend for Canadian tax purposes
Negative
- Dividends paid to non‑residents are subject to withholding tax
- Taxation for U.S. residents governed by the Internal Revenue Code
Details
News Market Reaction – CHHHF
On May 11, the first trading day after this news, CHHHF closed 4.13% below the previous close.
Data tracked by StockTitan Argus for the May 11 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - May 6, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the Company's Board of Directors has declared a dividend of CAD
About CareRx Corporation
CareRx is Canada's leading provider of pharmacy services to seniors living and other congregate care communities (long-term care homes, retirement homes, assisted living facilities and group homes). We are a national organization with a large network of pharmacy fulfillment centers strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education and medication system quality and efficiency.
For additional information, visit www.carerx.ca or contact:
Neil Weber
Investor Relations
LodeRock Advisors
647-222-0574
neil.weber@loderockadvisors.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296304
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.